Current Clinical Trials
Auceliciclib | AU 08
Clinical Trial of Auceliciclib in patients with advanced solid tumours – Phase I, Multi-Site, Australia (Protocol: AU08-001-01).
Lead Site: SOCRU, Bedford Park, SA, Australia
Medical Monitor: Dr Paul Wabnitz, MD, PhD, MBA, FRACP
Sponsor: Aucentra Therapeutics
Active Sites: SOCRU, Bedford Park | Sydney South West Private Hospital, Liverpool, NSW | Austin Health, Heidelberg, VIC
Status: Actively Recruiting
Clinical Trial Update | 24.02.2022
Aucentra Therapeutics is pleased to announce that it has received regulatory approval to progress to a Phase 1a/b clinical trial of Auceliciclib (AU3-14) in combination with Temozolomide for recurrent/refractory GBM patients. To read more, click here.